Joachim Thorkildsen
- Consultant; MD, PhD
Publications 2024
Controversies in orthopaedic oncology
Bone Joint J, 106-B (5), 425-429
DOI 10.1302/0301-620X.106B5.BJJ-2023-1381, PubMed 38689572
Publications 2023
Muscle strength characteristics following megaprosthetic knee reconstruction for bone sarcoma
Surg Oncol, 48, 101944
DOI 10.1016/j.suronc.2023.101944, PubMed 37062091
Intraosseous conventional central chondrosarcoma does not metastasise irrespective of grade in pelvis, scapula and in long bone locations
J Bone Oncol, 43, 100514
DOI 10.1016/j.jbo.2023.100514, PubMed 38033413
The national incidence of chondrosarcoma of bone; a review
Acta Oncol, 62 (2), 110-117
DOI 10.1080/0284186X.2023.2177975, PubMed 36856035
Publications 2022
Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based study
Acta Oncol, 61 (7), 793-800
DOI 10.1080/0284186X.2022.2082259, PubMed 35698755
Megaprosthesis for Metastatic Bone Disease-A Comparative Analysis
Curr Oncol, 29 (5), 3460-3471
DOI 10.3390/curroncol29050279, PubMed 35621669
Publications 2020
Chondrosarcoma local recurrence in the Cancer Registry of Norway cohort (1990-2013): Patterns and impact
J Surg Oncol, 123 (2), 510-520
DOI 10.1002/jso.26308, PubMed 33314135
Risk stratification for central conventional chondrosarcoma of bone: A novel system predicting risk of metastasis and death in the Cancer Registry of Norway cohort
J Surg Oncol, 121 (7), 1115-1125
DOI 10.1002/jso.25883, PubMed 32141094
Publications 2019
Chondrosarcoma in Norway 1990-2013; an epidemiological and prognostic observational study of a complete national cohort
Acta Oncol, 58 (3), 273-282
DOI 10.1080/0284186X.2018.1554260, PubMed 30632866
Publications 2014
Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study
Eur J Cancer, 51 (3), 374-81
DOI 10.1016/j.ejca.2014.11.007, PubMed 25529371